{
  "id": 6632716,
  "title": "XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™",
  "url": "https://urgent.news/2026/09/10/xortx-announces-initiation-of-clinical-and-commercial-manufacturing",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-10T20:07:01.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/xortx-announces-initiation-of-clinical-and-commercial-manufacturing-of-xorlo"
  },
  "original_language": "en",
  "account": null,
  "summary": "● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ● CALGARY, Alberta, Sept. 10, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}